References
- Ueki Y, Otsuka T, Windecker S, et al. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. Eur Heart J. 2020;41(22):2134.
- Singh B, Kaur P, Ajdir N, et al. Covid-19 presenting as acute limb ischemia. Cureus. 2020 Jul;12(7):e9344.
- Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020 Jul;18(7):1559–1561.
- Vasudev R, Guragai N, Habib H, et al. The utility of bedside echocardiography in critically ill COVID‐19 patients: early observational findings from three Northern New Jersey hospitals. Echocardiography. 2020 Aug 13;37(9):1362–1365.
- Bonow RO, Fonarow GC, O’Gara PT, et al. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020 March 27;5(7):751.
- Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799.
- Lax SF, Skok K, Zechner P, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, linicopathologic case series. Ann Intern Med. 2020;173(5):350. Epub 2020 May 14.
- Bikdeli B, Madhavan MV, Jimenez D. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020 June;75(23):2950–2973.
- Elkattawy S, Posimreddy S, Guragai N, et al. Extensive thrombosis in a severe COVID-19 patient despite prophylactic low molecular weight heparin. Cureus. 2020 Oct 25;12(10):e11152.
- Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020 Jul 7;76(1):122–124.
- Chen S, Zhang D, Zheng T, et al. DVT incidence and risk factors in critically ill patients with COVID-19 [published online ahead of print, 2020 Jun 30]. J Thromb Thrombolysis. 2020;1–7. DOI:10.1007/s11239-020-02181-w